Physician profile
Audrey Chang
NPI 1023075603
$475.22
in general payments reported to CMS, 2019-2025
12 companies · $81.96 in 2025
The $81.96 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112 · 2020: $17.09 · 2021: $56.31 · 2022: $37.43 · 2024: $171 · 2025: $81.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $185 · Long Term Medical Supply Or Device Loan: $68.21.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $184.67 |
| Long Term Medical Supply Or Device Loan | $68.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $68.21 | 2024 | Hillrom - Spot Vision Screener |
| Kaleo, INC. | $65.78 | 2019-2022 | |
| Glaxosmithkline, LLC. | $62.13 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $59.04 | 2024-2025 | Flumist Quadrivalent |
| Sobi, INC | $46.11 | 2019-2021 | |
| Sanofi Pasteur INC. | $36.20 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $35.18 | 2020-2021 | |
| Pfizer INC. | $27.78 | 2025 | |
| Ars Pharmaceuticals Operations, INC. | $25.04 | 2025 | Neffy |
| Ironshore Pharmaceuticals INC. | $18.41 | 2024 | |
| Seqirus USA INC | $18.20 | 2024 | Flucelvax |
| Merck Sharp & Dohme LLC | $13.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Audrey Chang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.